AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02972489 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Angio guidance arm
Description: In angiography-guidance group, wire recrossing into the side branch will be performed using conventional fluoroscopic/angiographic guidance. After finishing the procedure, OFDI is performed in the main branch but the results will be blinded to the operators.
Study NCT03334448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY900014-U200
Description: Administered SC
Study NCT03334448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY900014-U100
Description: Administered SC
Study NCT02425657 — intervention group
Intervention type: BEHAVIORAL
Intervention: Training of junior doctors
Description: Training program
Study NCT01107041 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobilyze!
Description: Mobilyze! delivers behavioral intervention for depression via a mobile phone, interactive website, and e-mail.
Study NCT03033381 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Color Doppler Ultrasound
Description: Radiological evaluation was performed by a single radiologist using CDUS for operated side testis of each patient preoperatively and on days 7 and 30 post-surgery. Longitudinal, anteroposterior, and transverse diameters of the testis were measured, and the testicular volume was calculated automatically using the CDUS device (volume = 0.523 × D1 × D2 × D3, where D1, D2, and D3 were the maximal longitudinal, anteroposterior, and transverse diameters defined by CDUS) for both testicles in each patient . Peak systolic velocity (PSV) was calculated using the CDUS system (in cm3/s) for both testicles in each patient.
Study NCT03033381 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Color Doppler Ultrasound
Description: Radiological evaluation was performed by a single radiologist using CDUS for nonoperated side testis of each patient preoperatively and on days 7 and 30 post-surgery. Longitudinal, anteroposterior, and transverse diameters of the testis were measured, and the testicular volume was calculated automatically using the CDUS device (volume = 0.523 × D1 × D2 × D3, where D1, D2, and D3 were the maximal longitudinal, anteroposterior, and transverse diameters defined by CDUS) for both testicles in each patient . Peak systolic velocity (PSV) was calculated using the CDUS system (in cm3/s) for both testicles in each patient.
Study NCT00940251 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mersina
Description: capsule, 3g/day, 3 months
Study NCT00940251 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mersina
Description: capsule, 3g/day, 3 months
Study NCT03933410 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KB195
Description: KB195 is a novel glycan
Study NCT04333511 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TPS (NEUROLITH)
Description: 6 treatments of TPS over 2 weeks
Study NCT04333511 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham-TPS (NEUROLITH)
Description: 6 treatments of Sham-TPS over 2 weeks
Study NCT01022372 — intervention group
Intervention type: PROCEDURE
Intervention: Endometrial biopsy
Description: For all the groups
Study NCT01701479 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ch14.18/CHO
Study NCT01701479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ch14.18/CHO
Study NCT01701479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aldesleukin
Study NCT01701479 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isotretinoin
Study NCT01701479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isotretinoin
Study NCT02944227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lucentis
Description: Lucentis fixed-treatment arm
Study NCT04272866 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinpro sealant
Description: Resin based sealant
Study NCT04272866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Embrace wetbond sealant
Description: Moisture tolerant hydrophilic resin based sealant
Study NCT04272866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Triage sealant
Description: Glass ionomer sealant
Study NCT01329731 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: elmex® gelée
Description: 1.25% fluoride (elmex® gelée) Dosage: Weekly brushing with 0.5g of respective gel Route: Intraoral topical
Study NCT01329731 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: negative control (placebo)
Description: 0% fluoride (negative control) Dosage: Weekly brushing with 0.5g Route: Intraoral topical
Study NCT03587012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brain fitness app
Description: Daily tutored sessions of brain exercises on an iPAD (in-person or remote)
Study NCT03587012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brain fitness app with tACS
Description: Daily tutored sessions of brain exercises on an iPAD with simultaneous transcranial alternating current stimulation (tACS)
Study NCT00806754 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ciclesonide nasal spray + placebo Azelastine
Description: Ciclesonide nasal spray 50 mcg + Placebo Azelastine
Study NCT00806754 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ciclesonide nasal spray + Azelastine
Description: Ciclesonide nasal spray 50 mcg + Azelastine 137 mcg
Study NCT04425174 — intervention group
Intervention type: PROCEDURE
Intervention: Quadratous lumborum block
Description: Quadratus Lumborum (QL) block is a new technique for analgesia of the abdominal wall muscles. Its mechanism depends on the injection of the local anesthetic agent between the abdominal wall muscles into the thoracolumbar fascia surrounding the Quadratus Lumborum muscle by ultrasound (US) guided technique.
Study NCT04425174 — intervention group
Intervention type: PROCEDURE
Intervention: Epidural anesthesia
Description: Epidural analgesia is a gold standard analgesic technique for the majority of abdominal surgeries, yet it has some limitations in some surgeries as colorectal surgeries due to delayed ambulation due to muscular weakness and postural hypotension.
Study NCT02908503 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo Film
Description: placebo vaginal films
Study NCT03180151 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: piezotome assisted orthodontic tooth movement
Description: Surgical procedure~1. After local anesthesia, vertical interproximal incisions will be done under the interdental papilla, on the labial aspect of upper arch using a blade No. 15.~2. The incisions will be kept minimal.~3. The incisions go though the periosteum, which permit the blade to reach to the alveolar bone.~4. A Piezo surgical knife will be used to make the cortical alveolar incision through the gingival incisions to a depth of approximately 3mm.~5. As we will not use bone graft so we don't need use suturing after cortication.~6. We give patient antibiotic and analgesic cover.
Study NCT03796429 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS+Toripalimab
Description: Patients will be given treatment as below once recruited: PD-1 antibody Toripalimab（240mg, iv, q3w），combined with GS regimen(gemcitabine 1000mg／m2 ，d1,d8 + S1 40-60mg bid\*14d，Q21d).~The treatment will be continued until emerging of disease progression or intolerable adverse effects (The upper time limit for treatment is 2 years).
Study NCT04341454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP14012 X mg
Description: DWP14012 X mg, tablet, orally, once daily for 2 weeks
Study NCT04341454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP14012 X mg placebo
Description: DWP14012 X mg placebo-matching tablet, orally, once daily for 2 weeks
Study NCT04341454 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DWP14012 X mg placebo
Description: DWP14012 X mg placebo-matching tablet, orally, once daily for 2 weeks
Study NCT04341454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP14012 Y mg
Description: DWP14012 Y mg, tablet, orally, twice daily for 2 weeks
Study NCT00392899 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: UFT adjuvant chemotherapy
Description: UFT is given at a dose of 500-600 mg/day as tegafur in 2 divided doses after meals for 5 days, followed by a 2-day rest. This one-week cycle is repeated for one year.
Study NCT00779194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rapamycin
Description: Rapamycin, is given to this group at a starting dose of 2 mg/day.
Study NCT04341454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP14012 Y mg placebo
Description: DWP14012 Y mg placebo-matching tablet, orally, twice daily for 2 weeks
Study NCT04341454 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DWP14012 Y mg placebo
Description: DWP14012 Y mg placebo-matching tablet, orally, twice daily for 2 weeks
Study NCT03272490 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Medartis
Description: Surgery using the medartis implant
Study NCT03272490 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Synthes
Description: Surgery using the Synthes implant
Study NCT02231333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-adenosylmethionine (SAMe)
Study NCT02231333 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pentoxiphylline (PTX)
Study NCT01817621 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental Intervention
Description: The experimental intervention arm will include the same measures as the TAU comparison study arm. In addition, participants will attend several sessions addressing body dissatisfaction, including psychoeducation on the antecedents and consequences of body dissatisfaction, the common comorbidity of depressed mood, and how these factors can affect HIV self-care behaviors.
Study NCT01817621 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Participants assigned to the TAU condition will receive appropriate services and referrals as needed, as would be typical of patients at Fenway Health or MGH, and will attend bi-weekly appointments with a study research assistant (RA) to complete study questionnaires and assess pocketed adherence, including HAART doses that participants may have taken outside of Wisepill.
Study NCT02594709 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Multisession Radiosurgery
Description: Patients will undergo multisession radiosurgery as clinical practice.
Study NCT02481804 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: Patients will be counseled by a dietician for 14 weeks. A tailored diet advice for each NET patient will be based on the individual situation which includes gastrointestinal complaints, the location of the tumor, additional treatments like previous surgery and measured vitamine and tryptophan levels.~Dietician consults will be conducted by 1 out-patient visit and 3 follow up contacts.
Study NCT02481804 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard treatment
Description: Standard treatment will be continued
Study NCT00372476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib and Vinorelbine
Study NCT00703391 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD9668
Description: 30mg oral tablets twice daily (bid) for 14 days
Study NCT00703391 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo to 30mg oral tablet twice daily (bid) for 14 days
Study NCT06432257 — intervention group
Intervention type: DEVICE
Intervention: head mounted magnifying glass assistance
Description: When performing thyroid surgery for patients in the experimental group, the surgeon uses a head mounted magnifying glass for assistance
Study NCT03607591 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: rTMS
Description: rTMS is a non-invasive and safe brain stimulation technique, that uses a magnetic pulse, administrated through a coil, set on the DLPFC
Study NCT03607591 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: rTMS
Description: rTMS is a non-invasive and safe brain stimulation technique, that uses a magnetic pulse, administrated through a coil, set on the DLPFC
Study NCT03989388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupational self-analysis
Description: The Occupational Self-Analysis program provides participants with a space where they can learn to analyse the barriers and supports for occupational participation.
Study NCT03210597 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The subjects performed training in aquatic environment
Study NCT03989388 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Vocational guidance
Description: To explore participant´s job interests and learned how to find a job and define a professional profile.
Study NCT03989388 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Rehabilitation
Description: Usual rehabilitation: occupational therapy and/or physiotherapy.
Study NCT01212913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INSULIN GLARGINE
Description: Pharmaceutical form: solution for injection Route of administration: subcutaneous Dose regimen: once daily
Study NCT01212913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INSULIN GLULISINE
Description: Pharmaceutical form: solution for injection Route of administration: subcutaneous Dose regimen: once daily
Study NCT01212913 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin aspart
Description: Pharmaceutical form: solution for injection Route of administration: subcutaneous Dose regimen: twice daily
Study NCT02869802 — intervention group
Intervention type: PROCEDURE
Intervention: Tumour Biopsy
Description: If there is the presence of a tumour lesion amenable to core needle biopsy as judged by a staff interventional radiologist, a minimum of 3 tumour cores will be obtained under CT or US guidance.
Study NCT02869802 — intervention group
Intervention type: OTHER
Intervention: Serial Collection of Plasma and Serum Samples
Description: Participants will undergo serial collection of plasma and serum samples at baseline and every 4 weeks until end of study.
Study NCT00779805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine hydrochloride 120 mg ER tablets
Study NCT00779805 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pseudoephedrine hydrochloride 120 mg ER tablets
Study NCT00772902 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Truvada + Kaletra
Description: Truvada (emtricitabine 200 mg/tenofovir DF 300 mg)once daily for oral administration according to prescription information. As third agent, continuing Kaletra (lopinavir 200 mg/ritonavir 50 mg) for oral administration according to prescription.
Study NCT00772902 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Kivexa + Kaletra
Description: Continuing Kivexa (abacavir sulfate 600 mg/lamivudine 300 mg) once daily for oral administration according to prescription. As third agent, continuing Kaletra (lopinavir 200 mg/ritonavir 50 mg) for oral administration according to prescription.
Study NCT01201837 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Weekly injection
Study NCT01201837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CER-001
Description: Weekly injection
Study NCT03253250 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ETV；TDF；ADV
Description: NAs
Study NCT03253250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ETV；TDF；ADV
Description: NAs
Study NCT03253250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon Alfa-2a
Description: peginterferon
Study NCT00687869 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Case management
Description: Case management with patient-information-notes, telephone hotline, individual counselling using home visits, e-mail and telephone contact, web portal
Study NCT00687869 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Case management
Description: Usual stroke aftercare plus patient-information-notes
Study NCT01489774 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: single and multiple dose
Study NCT01489774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CJ-12406
Description: single and multiple dose
Study NCT02766725 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: preparation F12 sildenafil in situ gel
Description: in situ vaginal gel
Study NCT02766725 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: preparation F2 sildenafil in situ gel
Description: in situ vaginal gel
Study NCT02766725 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo gel
Description: vaginal gel
Study NCT03912116 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CLARIX FLO
Description: 100mg CLARIX FLO
Study NCT03912116 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline
Description: Saline
Study NCT03912116 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Saline
Study NCT03259204 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Adjuvant IPC
Description: This IPC-system delivers sequential circumferential compression. The IPC device is mobile and should therefore not restrict patient mobilization, but can be taken off if the patient wants to mobilize independently.
Study NCT03544502 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CD player
Description: CD player opened during anesthesia induction and continued until postoperative 15 minute
Study NCT03544502 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CEL-480 Sound Level Meter Sonometre
Description: Noise level recordings were performed using CEL-480 Sound Level Meter Sonometre.
Study NCT03544502 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: CEL-480 Sound Level Meter Sonometre
Description: Noise level recordings were performed using CEL-480 Sound Level Meter Sonometre.
Study NCT03544502 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Earplug
Description: the independent anesthesiologist placed earplug into the patients' ears during anesthesia induction and the ear plug were removed immediately before tracheal tube extubation.
Study NCT03544502 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Ambient operating room noise
Description: patients were exposed to the ambient operating room noise.
Study NCT03735225 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasiglucagon
Description: Dasiglucagon injection
Study NCT03735225 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for Dasiglucagon injection
Study NCT04698902 — intervention group
Intervention type: DEVICE
Intervention: Intracoronary lithotripsy
Description: Intracoronary lithotripsy involves the use of sonic pressure waves generated from emitters enclosed within a balloon delivery system. The generated sonic waves act to fracture calcium within the coronary artery wall.
Study NCT00707824 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nalbuphine
Description: nalbuphine 5 mg epidural
Study NCT00707824 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nalbuphine
Description: nalbuphine 10 mg epidural
Study NCT00707824 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: NSS
Description: NSS
Study NCT01026467 — intervention group
Intervention type: DRUG
Intervention: cisplatin
Description: Given IV
Study NCT01026467 — intervention group
Intervention type: DRUG
Intervention: carboplatin
Description: Given IV
Study NCT01026467 — intervention group
Intervention type: OTHER
Intervention: questionnaire administration
Study NCT02229747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Meloxicam
Study NCT02229747 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac
Study NCT02229747 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nimesulide
Study NCT03705676 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rapid Arm Movements
Description: 240 trials of RAM in either a forward (50%) or backward (50%) shoulder flexion direction and back to neutral as fast as possible, with maintaining extension in the elbow. Visual cues (arrows) indicated the movement direction.
Study NCT03705676 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rapid Arm Movements
Description: 240 trials of RAM in either a forward (50%) or backward (50%) shoulder flexion direction and back to neutral as fast as possible, with maintaining extension in the elbow. Visual cues (arrows) indicated the movement direction.
Study NCT03705676 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Unpleasant stimulus
Description: An unpleasant, but harmless, electrocutaneous stimulus is administered to the low back region in 25% of the threat trials during the fear condition. Due to a conditioning phase before testing, participants know to expect this stimulus after the presentation of a warning cue related to the fear trials (either pink or blue dot dependent on randomization).